Kala Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/17/2026

1. SPY
2. EYPT
3. TSLA
4. NVDA
5. AWK
6. GNK
7. USO
8. ARGX
9. SPCX
10. AZN

Go back to Kala Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Corporate Update

Kala Pharmaceuticals (KALA) Misses Q1 EPS by 3c

May 7, 2020 7:44 AM EDT

Kala Pharmaceuticals (NASDAQ: KALA) reported Q1 EPS of ($0.54), $0.03 worse than the analyst estimate of ($0.51). Revenue for the quarter came in at $1.1 million versus the consensus estimate of $2.66 million.

The first quarter of 2020 was marked by substantial progress across our business, even as we contended with... More